Mynomx Pioneers the Personalization Science of Food Nutrition to Prevent and Fight Onset of COVID-19
Summary
PALO ALTO, Calif.--(BUSINESS WIRE)--Mynomx Inc. (formerly Precision Wellness, Inc.), a Silicon Valley-based company at the intersection of next-generation AI analytics and the latest medical and nutrition science, today announced their personalized nutrition approach to boosting cardio and metabolic health for disease prevention and immune system support. The Novel Coronavirus (COVID-19) has swept the world and struck those with underlying cardiometabolic syndrome: inflammation, hypertension, obesity, diabetes, and cardiovascular disorders, the hardest. The food that we eat directly affects the biochemical pathways that may result in a metabolic imbalance within every tissue and cell, including those of our immune system", explains Dr. Mehrdad Rezaee, Interventional Cardiologist at Cardiac and Vascular Care, a clinical scientist and a Mynomx co-founder. Mynomx combines this pattern with an individuals preference, to produce a curated list of foods ranked based on this precision nutrition score. The data-driven Mynomx analytic platform, powered by the latest in nutritional science at the molecular level, multi-omics, and next-generation AI, offers the means to manage health through "food as medicine," preventing disease and supporting healthy aging.